文献速递神经肿瘤神经重症

脑肿瘤切除开颅术围手术期血糖管理:全球神经麻醉医师认知与实践调查

Perioperative Glycemia Management in Patients Undergoing Craniotomy for Brain Tumor Resection: A Global Survey of Neuroanesthesiologists' Perceptions and Practices.
PubMed 文献 · World Neurosurg · 2021-09-01

该调查向北美、南美、欧洲和亚洲的神经麻醉医师发放在线问卷,了解脑肿瘤切除开颅术围手术期血糖管理的认知与实践。4周内共435名来自34个国家、6大洲的参与者完成调查。结果显示不同地区在血糖监测频率、手术推迟或取消的血糖阈值等方面存在差异,提示需要更强的临床证据和指南指导。

要点

  • 全球神经麻醉医师对脑肿瘤开颅术围手术期血糖管理的认知与实践存在差异。
  • 北美受访者比欧洲和南亚受访者更倾向于认为高血糖风险更高。
  • 北美受访者推迟或取消手术的血糖阈值高于斯拉夫、欧洲、南美及亚太地区受访者。

核心结论

  • 脑肿瘤切除开颅术围手术期血糖管理的认知与实践存在地区差异,需要更强临床证据和指南指导。

研究设计与样本

  • 在线问卷调查,对象为北美、南美、欧洲和亚洲的神经麻醉医师,4周内435名来自34个国家、6大洲的参与者完成调查。

主要发现

  • 北美受访者认为高血糖风险高于欧洲(P=0.024)和南亚(P=0.007)受访者。
  • 南亚(P=0.030)、中东(P=0.029)和南美(P=0.005)受访者比北美受访者更可能在切皮时初始血糖正常后复测血糖。
  • 北美受访者推迟或取消手术所需的血糖阈值高于斯拉夫(P<0.001)、欧洲(P=0.002)、南美(P=0.002)及亚太(P<0.001)受访者。
  • 北美受访者更可能报告因较高血糖阈值而推迟或取消手术。

临床怎么用

  • 调查结果提示临床实践中应关注地区间血糖管理差异,但具体决策仍需结合临床证据和指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is a paucity of clinical evidence that guides perioperative glycemia management in patients undergoing craniotomy for brain tumor resection. The purpose of this study was to better understand global perceptions and practices related to glycemia management in these patients. METHODS: Neuroanesthesiologists throughout North America, South America, Europe, and Asia filled out a brief online questionnaire related to their perceptions and practices regarding glycemia management in patients undergoing craniotomy for brain tumor resection. RESULTS: Over 4 weeks, 435 participants practicing in 34 countries across 6 continents participated in this survey. Although responders in North America were found to perceive a higher risk hyperglycemia compared with those practicing in European (P = 0.024) and South Asian (P = 0.007) countries, responders practicing in South Asian countries (P = 0.030), Middle Eastern countries (P = 0.029), and South American (P = 0.005) countries were more likely than those from North America to remeasure glucose after an initial normal glucose measurement at incision. Responders from North America reported that a higher blood glucose threshold was necessary for them to delay or cancel the surgery compared with responders in Slavic (P < 0.001), European (P = 0.002), South American (P = 0.002), and Asian and Pacific (P < 0.001) countries. Responders from North America were more likely to report that they would delay or cancel the surgery because of a higher blood glucose threshold. CONCLUSIONS: Our survey results suggest that perceptions and practices related to blood glucose management in patients undergoing brain tumor resection are variable. This study highlights the need for stronger clinical evidence and guidelines to help guide decisions for when and how to manage blood glucose derangements in these patients.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gruenbaum SE, Guay CS, Gruenbaum BF, et al. Perioperative Glycemia Management in Patients Undergoing Craniotomy for Brain Tumor Resection: A Global Survey of Neuroanesthesiologists' Perceptions and Practices. World Neurosurg. 2021. PMID: 34481106. doi:10.1016/j.wneu.2021.08.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。